Altered in vitro uptake of E-5-2-125iodovinyl-2'-deoxyuridine following administration of the antineoplastic agent etoposide.
The semi-synthetic epipodophyllotoxin derivative, etoposide (VP-16-213), has been shown to inhibit nucleoside uptake in mammalian cells. The present study examined whether etoposide (or the solvent in which it is usually supplied) affected the uptake of the radioiodinated antiviral nucleoside analogue E-5-2-125Iodovinyl-2'-deoxyuridine (125IVDU) by HSV1-infected cells (human herpesvirus 1; herpesvirus simplex type 1). Etoposide was found to significantly reduce 125IVDU sequestration, although some of this effect could be attributed to the solvent. The results are discussed in relation to the use of etoposide in the development of a specific, scintigraphic brain imaging technique to enable early diagnosis of herpes encephalitis.
Lewis
A G
AG
Dept of Medical Microbiology, University of Manchester, Medical School, UK.
Klapper
P E
PE
Cleator
G M
GM
Templeton
P P
PP
Longson
M
M
D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism*; D004660:Encephalitis / Q000175:diagnosis; D005047:Etoposide / Q000494:pharmacology*; D006561:Herpes Simplex / Q000175:diagnosis; D007065:Idoxuridine / Q000031:analogs & derivatives* / Q000378:metabolism; D018139:Simplexvirus / Q000187:drug effects* / Q000378:metabolism; D014709:Vero Cells
D000998:Antiviral Agents; C030360:5-(2-iodovinyl)-2'-deoxyuridine; D005047:Etoposide; D007065:Idoxuridine